puromycin aminonucleoside and Glomerulonephritis, IGA

puromycin aminonucleoside has been researched along with Glomerulonephritis, IGA in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asanuma, K; Fukuda, H; Hidaka, T; Ichimura, K; Oliva Trejo, JA; Sakai, T; Sasaki, Y; Takagi-Akiba, M; Tomino, Y; Wang, J1
Furness, PN; Harris, K1

Reviews

1 review(s) available for puromycin aminonucleoside and Glomerulonephritis, IGA

ArticleYear
An evaluation of experimental models of glomerulonephritis.
    International journal of experimental pathology, 1994, Volume: 75, Issue:1

    Topics: Animals; Antigen-Antibody Complex; Autoimmune Diseases; Disease Models, Animal; Evaluation Studies as Topic; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental; Humans; Mice; Nephrosis, Lipoid; Puromycin Aminonucleoside; Serum Sickness; Species Specificity

1994

Other Studies

1 other study(ies) available for puromycin aminonucleoside and Glomerulonephritis, IGA

ArticleYear
Podocin is translocated to cytoplasm in puromycin aminonucleoside nephrosis rats and in poor-prognosis patients with IgA nephropathy.
    Cell and tissue research, 2015, Volume: 360, Issue:2

    Topics: Animals; Cytoplasm; Glomerulonephritis, IGA; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Nephrosis; Podocytes; Prognosis; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley

2015